Time to Benefit With Sotagliflozin in Patients With Worsening Heart Failure

J Am Coll Cardiol. 2023 Apr 18;81(15):1546-1549. doi: 10.1016/j.jacc.2023.02.022.
No abstract available

Publication types

  • Letter

MeSH terms

  • Diabetes Mellitus, Type 1*
  • Glycosides
  • Heart Failure* / drug therapy
  • Humans
  • Hypoglycemic Agents

Substances

  • (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
  • Glycosides
  • Hypoglycemic Agents